Each year the Graduate Student Council sponsors the Student Research Forum (SRF). A three-day interactive event, this year's SRF will be held on April 2-4, 2014. It will showcase research conducted by students from the schools of medicine, nursing, health professionals, and graduate studies on Wednesday, April 2, 2014. In addition to the student presentations, the SRF features a banquet (April 3, 2014) and the extremely popular A.L Chapman Keynote Research Lecture scheduled on Friday, April 4, 2014 focused on the professional development of attendees.
The A.L. Chapman Lecture series was created in honor of A.L. Chapman, Professor Emeritus of Anatomy & Cell Biology and Vice Chancellor for Academic Affairs Emeritus.
The 2014 A.L.Chapman Keynote Lecture will be presented by Dr. Mark Levine, Chief of Molecular and Clinical Nutrition and a Senior Staff Physician at NIDDK, NIH.
Dr. Levine received his undergraduate degree from Brandeis University and his medical degree from Harvard Medical School. He completed training in Internal Medicine at Johns Hopkins Hospital and in Endocrinology and Metabolism at NIH, and is certified by the American Board of Internal Medicine in these specialties. Throughout his career, Dr. Levine has been both a practicing physician and a scientist. He is the author of more than 250 peer reviewed articles, chapters, books, and abstracts and is recognized internationally for his comprehensive biochemical and clinical work on vitamin C, or ascorbic acid. Work from Dr. Levine's laboratory is the basis for vitamin C intake recommendations worldwide (U.S., Canada, Japan, Germany, France, Denmark, Austria, China). Dr. Levine is a member of the American Society for Clinical Investigation and the American College of Physicians and a Fellow of the American College of Nutrition. He was the 2007 Linus Pauling Prize recipient from Oregon State University ($50,000 + medal); has received numerous other awards; and lectures nationally and internationally on vitamin C. Work from Dr. Levine's laboratory has shown unexpected and exciting promise of pharmacologic ascorbic acid in treating cancer. His long-range goals are to determine ideal vitamin ingestion in humans in health and disease using concentration-function principles and ascorbic acid as a model; to realize the full potential of ascorbic acid as a pharmacologic agent for disease treatment; to explore unexpected promise of ascorbic acid in treating complications of diabetes; and to utilize concentration-function and pharmacokinetics principles to establish recommendations for other vitamins.